发明授权
US06838475B2 Imidazolidinones as NS3-serine protease inhibitors of hepatitis C virus
失效
咪唑啉酮作为丙型肝炎病毒的NS3-丝氨酸蛋白酶抑制剂
- 专利标题： Imidazolidinones as NS3-serine protease inhibitors of hepatitis C virus
- 专利标题（中）： 咪唑啉酮作为丙型肝炎病毒的NS3-丝氨酸蛋白酶抑制剂
-
申请号： US09909077申请日： 2001-07-19
-
公开(公告)号： US06838475B2公开(公告)日： 2005-01-04
- 发明人: Ashok Arasappan , Tejal Parekh , F. George Njoroge , Viyyoor Moopil Girijavallabhan , Ashit K. Ganguly
- 申请人： Ashok Arasappan , Tejal Parekh , F. George Njoroge , Viyyoor Moopil Girijavallabhan , Ashit K. Ganguly
- 申请人地址： US NJ Kenilworth
- 专利权人： Schering Corporation
- 当前专利权人： Schering Corporation
- 当前专利权人地址： US NJ Kenilworth
- 代理商 Palaiyur S. Kalyanaraman
- 主分类号： C12N9/99
- IPC分类号： C12N9/99 ; A61K31/4166 ; A61K31/7056 ; A61K38/00 ; A61K38/21 ; A61K38/55 ; A61K45/00 ; A61P31/14 ; A61P43/00 ; C07D233/38 ; C07K5/02 ; C07K5/023 ; C07K5/062 ; C07K7/02 ; A01N43/50
摘要：
The present invention discloses novel imidazolidinones which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such imidazolidinones as well as methods of using them to treat disorders associated with the HCV protease.
公开/授权文献
信息查询
